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M ore than 40% of stroke survivors are found with cognitive impairment (poststroke cognitive impairment [PSCI] ) sometime after the event.
1 Almost two thirds of these patients are affected by mild cognitive impairment (MCI). 2 A meta-analysis showed that 10% of patients had dementia before first stroke, 10% developed dementia soon after first stroke, and more than a third had dementia after recurrent stroke. 3 Ideally, cognitive evaluation of patients with stroke should start early after the event, but this may be difficult. In fact, a cognitive evaluation is not a part of the routine assessment of patients with acute stroke in most centers, and items assessing cognitive functions are poorly represented in the most widely used acute stroke scales.
The Montreal Cognitive Assessment (MoCA) is a brief screening instrument originally designed to identify MCI in elderly patients attending a memory clinic. 4 MoCA is a 1-page, 30-point test, administrable in ≈10 minutes, which evaluates different domains: visuospatial abilities, executive functions, short-term memory recall, attention, concentration, working memory, language, and orientation to time and space ( Figure) . 5 A shortened version of MoCA has been proposed as a first assessment of patients with vascular cognitive impairment by a consensus conference. 6 When compared with another widely used cognitive screening test, the Mini Mental State Examination (MMSE), one of the possible strengths of MoCA in the vascular patient setting is the assessment of executive functions and the presence of more demanding visual construction tasks. 7 The consensus conference proposal was generally directed to not otherwise specified vascular cognitive impairment patients 6 ; however, MoCA has recently been used by various groups in the research stroke setting (online-only Data Supplement). However, the use of MoCA in usual stroke practice is not frequent. 8 In this article, we reviewed the literature on the use of MoCA in patients with stroke. We dealt separately with articles in which the test was administrated in the acute/subacute (the first 4 weeks after stroke) or in the chronic phase after stroke (any time after the first 4 weeks). The aim of this review is to spotlight the diffusion, the main results, the indications, and limitations of the use of MoCA in the stroke setting. This work could serve to implement the use of MoCA in the stroke setting and establish a first level of knowledge about the advantages and limitations of this test. Suggestions and research lines for future studies aimed at better establishing the role of MoCA in this setting may derive from this review.
Article Search Strategy and Selection Criteria
Articles were identified through PubMed searches using the terms: Montreal Cognitive Assessment, MoCA, stroke, hemorrhage, poststroke, poststroke, vascular cognitive impairment, from any date to December 31, 2013. Only articles in which MoCA was cited in title or abstract and written in English were reviewed in detail. Further references were obtained from the reference lists of the articles identified through the search. The final reference list was generated on the basis of relevance to the topic of this review.
Use of MoCA in the Acute/Subacute Poststroke Phase
It is likely that patients with PSCI might be already identified soon after stroke by a neuropsychological evaluation, thus outlining a factor possibly relevant in prognostic, therapeutic, and rehabilitation terms. However, several conditions may influence the applicability and reliability of a cognitive evaluation early after stroke, when extensive testing does not seem routinely feasible on a large scale. A brief, easy-to-use, test such as MoCA could be useful in this context. Considering the MoCA applicability in the acute stroke setting, we showed that the test administration was feasible in patients with mild-to-moderate stroke, and that MoCA was fully applicable in 73% of all patients admitted to our stroke unit with either ischemic or hemorrhagic strokes. 9 The independent determinants of its applicability were left-side lesion location, stroke severity, and premorbid functional status.
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attack, 8, [10] [11] [12] [13] hemorrhages, 10, 14 severe stroke, 15 major physical disability, 14, [16] [17] [18] significant aphasia, 8, 10, 11, 13, [16] [17] [18] inability to participate in rehabilitation activities, 8 prestroke cognitive impairment, [15] [16] [17] acute delirium, 17 and major psychiatric disorder. 10, 11, 14, [16] [17] [18] [19] These exclusion criteria led to apply MoCA mostly in mild-to-moderate patients with stroke, usually with first-ever ischemic stroke, without other major disorders or severe aphasia. The fact that patients with severe neurological status or aphasia cannot be tested with MoCA is not necessarily a major limitation of this tool because these patients are already candidates for specific rehabilitation programs or long-term care strategies.
psychocognitive assessment tools and discharge functional outcome. When compared with the MMSE, MoCA had more frequently altered items, 8, 10, 11, 16, 18 less ceiling effect, 8, 16 but a similar correlation with discharge motor outcome 8 and with an extensive neuropsychological evaluation. 11 In 1 study, no correlation was found between MoCA performances and apathy or depression within 2 weeks of stroke onset. 19 MoCA also identified more patients with cognitive abnormalities than the MindStreams, a 45-minute computerized neuropsychological assessment battery that examines a wide range of cognitive domains. 15 To establish the prognostic value of MoCA, 3 studies compared MoCA performances in the acute/subacute poststroke period with those on extensive neuropsychological batteries at midterm follow-up. 12, 17, 20 These studies showed that baseline MoCA can predict the development of PSCI at 3, 6, and 12 months with an accuracy of ≥90%. In our study, MoCA baseline score was an independent determinant of PSCI with an odds ratio 1.4 for each test point lost. 20 MoCA score was also associated with poor functional status measured with the modified Rankin Scale at 3 to 6 months in patients with ischemic stroke or transient ischemic attack 14 and at 12 months in patients with subarachnoid hemorrhage.
13

Use of MoCA in the Chronic Poststroke Phase
The presence of poststroke cognitive impairment 3 months after the event is associated with death or disability at 3 and 4 years (odds ratio, 2.0 and 2.2, respectively) and greater institutionalization rates. 21 Hence, repeating a cognitive evaluation in the midterm follow-up of stroke is crucial for identifying those patients that would need more care and, possibly, specific interventions. After the subacute poststroke phase, patients are supposedly more stable, and it is possible that some spontaneous cognitive recovery has already occurred. Again, a comprehensive neuropsychological battery, the gold standard for the diagnosis of cognitive impairment, might not be feasible in the routine practice because it is time-consuming and require trained personnel, and hence a short and reliable test would be worthwhile to use in this phase.
The feasibility of the application of MoCA in patients with stroke at a 3-month follow-up was evaluated by Cumming et al. 22 The test was completed by 87% of patients with mild stroke (baseline National Institutes of Health Stroke Scale, 0-7), 79% of those with moderate stroke (National Institutes of Health Stroke Scale, [8] [9] [10] [11] [12] [13] [14] [15] , and 67% of those with severe stroke (National Institutes of Health Stroke Scale, >16). 22 Sixty-five percent of patients examined were classified as affected by PSCI; the items most frequently impaired were those with attention and executive demands and word recall. 22 Many studies compared MoCA with other single cognitive tests or neuropsychological batteries to estimate its accuracy in detecting PSCI in the chronic poststroke phase. When MoCA was compared with MMSE, a larger number of patients with stroke or transient ischemic attack was found with scores under the range of normality. 23, 24 Similar results were reported in out-patients affected by cerebrovascular diseases. 25 Nevertheless, the MoCA recall task, that is considered harder than the one of the MMSE, showed a floor effect in differentiating patients with more severe impaired recall. 26 MoCA was also compared with the Addenbrooke's Cognitive Examination-Revised, another short test that includes frontal executive and attention tasks, for the ability in detecting MCI. 24 MoCA and Addenbrooke's Cognitive ExaminationRevised had good sensitivity and specificity, suggesting that both tests were useful in detecting cognitive impairment in patients with stable cerebrovascular disease.
When MoCA was compared with neuropsychological batteries in patients with stroke caused by small-vessel diseases, it showed a significant relationship with an extensive battery and a good accuracy in detecting cognitive impairment when optimal cut-off values were found. 27 The same results were detected in another Asiatic sample of patients with small-vessel disease (not all of them with stroke). 28 Two studies compared MoCA and MMSE 3 to 6 months after aneurysmal subarachnoid hemorrhage. 29, 30 MoCA was more sensitive than MMSE in detecting PSCI in patients who had returned to work, and, unlike MMSE, correlated with performances on a comprehensive neuropsychological battery and with the functional outcome (Glasgow Outcome Scale). 29 Wong et al 30 examined the ability of MoCA and MMSE to differentiate favorable functional outcome (modified Rankin Scale, 0-2) and Instrumental Activities in Daily Living score in patients with postaneurysmal subarachnoid hemorrhage and found similar accuracy for both tests at their optimal cutoff values.
Considering the possible influence of cognitive performances on stroke motor outcome and rehabilitation, Hwang et al 31 found a significant correlation between MoCA score and some postural control and gait performances tests in patients with hemiparetic stroke. MoCA was also a predictor of maximal exercise effort on a graded exercise test in patients with stroke. The choice of the normality cut-off score for MoCA in patients with stroke is a crucial issue. Godefroy et al, 11 using published norms, found that 82% of their patients with acute stroke had a score below the normality. When the cut-off was adjusted for education and age, the proportion of patients decreased to 48%. 11 Similarly, Lees et al, 33 using the original cut-off of 26, diagnosed cognitive impairments in 86% of acute stroke unit patients; the proportion decreased to 49% if the cut-off was decreased to 20. Most studies found that the cut-off of 26, suggested by Nasreddine et al 5 to detect MCI in a memory clinic, is inadequate for the stroke setting. The optimal values for normality range from 19 to 22 in studies in which MoCA was administered in the acute stroke phase, 11, 12, 17, 20 and from 20 to 27 in studies in which the test was administered in the chronic phase, 24, 27, 28, 30, [34] [35] [36] once performances were compared with those on extensive batteries at follow-up.
Moreover, the proposed addition of 1 point to North America patients with <12 years of education 5 could not be adequate to patients with different social background, 37 as
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shown in some Asian and European studies 11, 16, 17 ; some of these studies found a threshold of 6 years of education for adding 1 point to MoCA total score. 28, 36 Another methodological problem when selecting the optimal cut-off score for MoCA normality is the choice of the thresholds to define cognitive impairment in the gold standard. 34, 38 Using the standard threshold of >1 SD below the mean in ≥2 domains in the gold standard battery, MoCA showed higher sensitivity than MMSE using a cut-off value of 24. 34 When a more conservative threshold (>2 SD in ≥2 domains) was used, this superiority in sensitivity was lost, and MMSE showed a even slightly greater accuracy than MoCA. 34 Pendlebury et al 38 investigated the sensitivity, specificity, accuracy, and optimal cut-off values of MoCA and MMSE in detecting MCI based on different thresholds on cognitive tests (>1, >1.5, and >2 SD below norms); they also differentiated between the Petersen's original (subjective memory complain required) and modified MCI criteria (without subjective memory complain). 38 MoCA seemed superior to MMSE in detecting MCI with modified criteria, whereas MMSE was better in detecting patients with MCI and subjective memory complains. 38 These findings corroborate the supposed superiority of MoCA in the vascular setting, where the nonamnestic single-domain is supposedly prevalent. 38 This study showed that the differences between MoCA and MMSE found in other studies almost disappeared when requirement for MCI was more stringent.
38
Shorter and Telephone Versions of MoCA
Shorter versions of MoCA have been developed to minimize the administration time further. A telephone version of MoCA (total score, 22; cut-off, 19 ) and its shorter version (total score, 12; verbal fluency, recall and orientation, cut-off, 11) were developed by Pendlebury et al. 39 Both versions had good accuracy in detecting MCI but performed worse than the original MoCA.
39
According to the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network (NINDS-CSN) statements, a 5-minute protocol based on MoCA items should include the 5-word immediate and delayed memory test, the 6-item orientation task, and the 1-letter phonemic fluency test (letter F). 7 Two studies tested this proposal in samples of patients with cerebrovascular disease 40, 41 and found that the MoCA subitems that more strongly correlated with MoCA total score were delayed recall, clock-drawing, and abstraction with an arbitrary cut-off of 7 of 10 in one study, 40 and verbal fluency, cube copy, trail making test, delayed recall, and abstraction with a calculated cut-off of 7 of 10 in another.
41
MoCA as an Outcome Cognitive Measure
MoCA is mainly considered a screening tool, but it has also been used as cognitive outcome measure in some studies. Cumming 
Conclusions
From the studies we reviewed, the use of MoCA as a brief cognitive tool in both the acute/subacute and chronic poststroke periods seems overall feasible. Used in the acute period, MoCA has a good predictive value for the development of PSCI in the follow-up. Shorter versions of MoCA are available to make the application of MoCA even faster without significantly decreasing its sensitivity and specificity. In the chronic, midterm poststroke period, MoCA is related to physical performances and to functional outcome, has a good correlation with other short cognitive tests, and shows high sensitivity and specificity in predicting PSCI in both ischemic and hemorrhagic strokes.
Some issues, however, remain open as pointed out by a recent review on the MoCA characteristics and methodological limitations of its use in patients with vascular cognitive impairment. 44 For example, the cut-off and the correction for education need to be redefined for the stroke setting and the different ethnic and educational groups. Because in the acute/ subacute stroke period a brief screening test should individuate those patients who may need further assessment, the cutoff should be selected to minimize the false-negative rate and the likelihood of a negative test. 45 The evaluation of cognition in patients with stroke is important and the use of a brief cognitive test may facilitate this assessment since the early phases. In this regard, it should be noted that available data do not sustain a clear superiority of MoCA in respect to other tools. However, MoCA presents some advantages, such as shortness, easiness of use, availability in different languages, and the free access (Table) . The Table also reports the disadvantages of MoCA use in the stroke population. Besides, the already made comments about norms and cut-off, it should be pointed out that domains that are often impaired after stroke, such as intellectual functioning, In consideration of all the points above discussed, a multicentric, hopefully international, study enrolling an appropriate number of patients with stroke seems warranted. Such a study should test patients with stroke and MoCA and other brief cognitive tests in the acute phase and then follow them up to define the diagnosis of cognitive impairment (either mild or severe) and explore the predictive values of MoCA according to different cut-offs, controlling for age, sex, and education. This study could also explore definitively whether MoCA is superior, equivalent, or even inferior to other brief cognitive tools. The MoCA (cut-off 26) picked up substantially more cognitive deficits than the MMSE (cut-off 27) in patients with TIA or stroke. 58% of patients with normal MMSE had abnormal MoCA, and these patients were more dependent on the mRS than those with normal MoCA. While the MoCA differentiated well between different levels of cognitive ability, the MMSE had a clear ceiling effect; >50% the patients with MMSE scores >27 were designated as cognitively impaired using the MoCA. The multivariate analysis showed that the reaction times of acute stroke patients on simple computerized tasks were related to attentional function assessed at 3 months poststroke. There was a significant relationship between speed of processing task at baseline and MoCA score at 3 months after the stroke. Stroke Assessment (CMSA) and two tests for walking ability were used together with the GXT. Patients were dichotomized in 2 groups using the age-predicted maximal heart rate.
The multiregression analysis revealed that CMSA lower limb impairment (OR 2.3) and MoCA (OR 1.3) were significant contributors to the participants' ability to achieve agerelated maximal heart rate. Age and NIHSS score remained in the model, but were not significant independent contributors. To evaluate the effects of a 6-month exercise program of aerobic and resistance training on cognition in patients with motor impairments ≥10 weeks post--stroke Outcome measures were conducted at baseline and following 6 months of exercise training (90min exercise class once a week) in the same order: CES-Depression scale, MoCA and duel-energy X-ray absorptiometry (DXA) scan.
In patients with residual motor impairment post-stroke, a 6-month combined aerobic and resistance training exercise program resulted in significantly improved MoCA scores and a 44.5% reduction in the proportion of patients meeting threshold criteria for MCI (MoCA cut-off <25). Improvement was characterized by gains in the subdomains of attention/concentration and visuospatial/executive functioning. The cognitive improvement was independently associated with fat-free mass accretion of no affected limbs. To identify the effects of falls experience on cognitive function, postural control, and gait performance in patients with chronic hemiparetic stroke and to evaluate the feasibility of using the MoCA to predict falls in stroke patients.
MoCA, the Berg Balance Scale (BBS), the Dynamic Gait Index (DGI), the Timed Up-and-Go (TUG) Test, the 10 Meter Walk Test (10MWT), and the 6 Minute Walk Test (6MWT) were administered at 25 patients with falls experience (fallers group) and 22 patients without falls experience (non-fallers group) in the previous 6 months.
MoCA was significantly correlated with the 6MWT, BBS, DGI, and the TUG test in the fallers group. In the no faller group, MoCA was significantly correlated with the 10MWT and DGI. This study also showed the feasibility of using the MoCA for predicting the risk of falls in community-dwelling stroke patients. Patients were tested at 1-or 5-year follow-up with MoCA and the NINDS-CSN VCI Harmonization Standards Neuropsychological Battery. At least 1 month after neuropsychological testing, they were tested with TMoCA (22 points) and TICSm presented in counterbalanced order. The T-MoCA-Short (verbal fluency, recall, and orientation; total 12 points), recommended by NINDS-CSN VCI group, was also considered.
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The T-MoCA and the TICSm had similar AUC curves and reasonable sensitivity and specificity for MCI, although the TMoCA-Short performed less well and face-to-face MoCA was better. Performance was better and more similar for all tests in detecting multiple-domain impairment. Patients were tested at 3 months post-stroke follow-up with MoCA and MMSE and then re-tested 1 week later with a comprehensive neuropsychological battery. Patients were divided into 3 groups of severity. Cut-off of both tests were found with AUC of ROC Using criterion standard of >1 SD in 2 or more domains, MoCA (optimal cut-off 27) exhibited acceptable validity and better AUC than MMSE (optimal cut-off 24) in identifying PSCI, with a good sensitivity even at the mild end of the PSCI spectrum (no ceiling effect). Using >1.5 SD and then >2 SD to detect only more severely cognitively impaired patients, MoCA superiority in sensitivity was lost. MoCA had greater predictive validity for patients with right hemisphere stroke compared with left hemisphere stroke. ACS outcomes were comparable to minor stroke and were worse than that after TIA. The cognitive profile of ACS was more similar to that of memory clinic patients. There was a lack of significantly different performance between ACS and TIA/stroke patients on the recall (and repetition) subtest of MoCA, probably because this task is more difficult in MoCA than in MMSE, resulting in floor effect and inability to differentiate between subjects with more impaired recall. MoCA (cut-off 26) and MMSE (cut-off 26) were administered to minor stroke (NIHSS<4) or TIA patients at their 3-month follow-up. Favorable outcome was mRS 0-1. Individual subtest of MoCA were converted using z-score to find the 5 most useful subtest to achieve a shortMoCA.
MoCA detected PSCI in 55% of patients, MMSE did it in 13%. In a multivariate analysis, MoCA <26 was associated with the outcome (OR 3.00), as were remote lacunar stroke and white matter changes of at least moderate severity. Five subtest (5-word recall, word list generation, trail making test, abstract reasoning, and cube copy) formed an optimal short-MoCA with 7/10 or less as good cut-off for VCI. To assess the effect of education level on MoCA screening for VCIND after ischemic stroke.
Ischemic CVD patients were divided into 2 groups (not cognitively impaired or VCIND) and tested with MoCA. Every group was then divided in three educational levels. 1 point was added if education was <12 years
MoCA was an effective screening tool for evaluating early cognitive impairment in VCIND patients. However, the MoCA naming factor did not differentiate between VCIND and in all three educational groups. In the other groups, other subtests could differentiate between VCIND and not cognitively impaired. This suggested that an increase in the educational level reduced the effectiveness of MoCA screening for some factors. The optimal cut-off value was 23, with a low sensitivity and specificity compared with other studies (65% and 79%), probably due to the different educational levels. 
